Atomfair 6-(bromomethyl)-2-methyl-4aH-quinazolin-4-one C10H9BrN2O

Description 6-(Bromomethyl)-2-methyl-4aH-quinazolin-4-one (CAS No. 112888-43-4) is a high-purity brominated quinazolinone derivative with the molecular formula C10H9BrN2O. This heterocyclic compound features a reactive bromomethyl group at the 6-position, making it a versatile intermediate for organic synthesis, medicinal chemistry, and pharmaceutical research. With a molecular weight of 253.10 g/mol, it is supplied as a crystalline solid with ??95% purity (HPLC). Ideal for nucleophilic substitution reactions, cross-coupling, and scaffold diversification, this compound is rigorously tested for consistency and stability. Store under inert conditions at 2-8??C to maintain reactivity.

Description

Description

6-(Bromomethyl)-2-methyl-4aH-quinazolin-4-one (CAS No. 112888-43-4) is a high-purity brominated quinazolinone derivative with the molecular formula C10H9BrN2O. This heterocyclic compound features a reactive bromomethyl group at the 6-position, making it a versatile intermediate for organic synthesis, medicinal chemistry, and pharmaceutical research. With a molecular weight of 253.10 g/mol, it is supplied as a crystalline solid with ??95% purity (HPLC). Ideal for nucleophilic substitution reactions, cross-coupling, and scaffold diversification, this compound is rigorously tested for consistency and stability. Store under inert conditions at 2-8??C to maintain reactivity.

  • CAS No: 112888-43-4
  • Molecular Formula: C10H9BrN2O
  • Molecular Weight: 253.09
  • Exact Mass: 251.98983
  • Monoisotopic Mass: 251.98983
  • IUPAC Name: 6-(bromomethyl)-2-methyl-4aH-quinazolin-4-one
  • SMILES: CC1=NC(=O)C2C=C(C=CC2=N1)CBr

Application

6-(Bromomethyl)-2-methyl-4aH-quinazolin-4-one serves as a key building block in the synthesis of quinazoline-based drug candidates, particularly kinase inhibitors and anticancer agents. Its bromomethyl group enables facile functionalization via Suzuki-Miyaura coupling or alkylation reactions. Researchers utilize this compound to develop novel heterocyclic frameworks for target identification and lead optimization in medicinal chemistry programs. It is also employed in material science for constructing fluorescent probes.

If you are interested or have any questions, please contact us at support@atomfair.com